(Q41681444)

7 October 2017

1 reference

title

Overview of lamotrigine and the new antiepileptic drugs: the challenge (English)

1 reference

7 October 2017

1 reference

J M Pellock

1

1 reference

7 October 2017

publication date

1 November 1997

1 reference

Journal of Child Neurology

7 October 2017

published in

1 reference

7 October 2017

volume

12 Suppl 1

1 reference

7 October 2017

page(s)

S48-52

1 reference

New antiepileptic drugs in children: present and future

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0883073897012001111

Reappraisal of polytherapy in epilepsy: a critical review of drug load and adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073897012001111

Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073897012001111

Lamotrigine in childhood epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073897012001111

Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073897012001111

Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073897012001111

Diagnosis and treatment of epilepsy in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073897012001111

Severe adverse cutaneous reactions to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073897012001111

10.1177/0883073897012001111

21 January 2018

Identifiers

DOI

0 references

1 reference